Diabetes medications

Five advancements in diabetes treatment to watch
Five advancements in diabetes treatment to watchThe healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.
Four biggest challenges in diabetes health managementWe recently asked experts to define the top challenges associated with diabetes health management, and how health plans can overcome them.
Three ways to increase compliance among diabetic patientsStudies have found that getting diabetes under control early on has immediate benefits. Here’s how providers and patients can more proactively address the disease.
Brand and specialty drug spending spikes
Brand and specialty drug spending spikesSpending on brand name drugs spiked 16.2% in 2015 and 98.2% since 2011, according to a new report from pharmacy benefit manager (PBM) Express Scripts. Plus, a third of branded products experienced price increases greater than 20% in 2015, according to Express Scripts’ annual Drug Trend Report.
Major diabetes drug cuts heart attack riskNew data from Novo Nordisk will help its Victoza (liraglutide) for type 2 diabetes better compete against Eli Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin). Victoza significantly reduced the combined incidence of heart attack, stroke and cardiovascular death in high-risk Type 2 diabetes patients, according to Novo Nordisk